Report
Jonathan Moreland
EUR 9.33 For Business Accounts Only

InsiderInsights Daily Ratings Report: February 26, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
180 Degree Capital

22nd Century Group Inc.

22nd Century Group is a plant biotechnology company focused on technology that allows the company to alter the level of nicotine and other nicotinic alkaloids in tobacco plants and the levels of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company's products include:Very Low Nicotine Content Cigarettes, which contains less nicotine to reduce smokers' exposure to nicotine, which is the primary addictive component of cigarettes under the product names of Moonlight? and Moonlight Menthol?; and SPECTRUM? Government Research Cigarettes, which supplies cigarettes with different nicotine contents (from very low to high) to National Institute on Drug Abuse.

Calamos Long/Short Equity and Dynamic Income Trust

Cannae Holdings

Cannae is a holding company engaged in managing and operating a group of companies and investments. The company's segments are: Restaurant Group, which consists of the operations of American Blue Ribbon Holdings, LLC and 99 Restaurants Holdings, LLC; Ceridian, which consists of the operations of the company's subsidiary, Ceridian HCM Holding, Inc., a global human capital management software company; T-System, which consists of the operations of the company's subsidiary, T-System Holdings, LLC, a provider of clinical documentation and coding solutions; and Corporate and Other, which consists of the company's share in the operations of controlled and uncontrolled portfolio companies.

HV Bancorp

HV Bancorp is a bank holding company. Through its subsidiary, the company's principal business consists of accepting retail deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, primarily in one- to four-family residential mortgage loans, home equity loans and home equity lines of credit and commercial real estate loans (including multi-family loans) and commercial and, to a lesser extent, construction and consumer loans. The company also invests in various investment securities. The company primarily serve communities located in Montgomery, Bucks and Philadelphia Counties in Pennsylvania and New Castle county in Delaware.

Ironwood Pharmaceuticals Inc. Class A

Ironwood Pharmaceuticals is a gastrointestinal (GI), healthcare company focusing on developing the treatment of GI diseases. The company's commercial product, LINZESS? (linaclotide), a guanylate cyclase type C agonists, is indicated for adult men and women suffering from irritable bowel syndrome with constipation, or chronic idiopathic constipation. In addition, the company is developing MD-7246, an oral, intestinal, non-opioid, pain-relieving agent for patients with abdominal pain associated with certain GI diseases. The company is also developing IW-3718, a gastric retentive formulation of a bile acid sequestrant for the potential treatment of refractory gastroesophageal reflux disease.

Kala Pharmaceuticals Inc.

Kala Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics using its AMPPLIFY? Mucus Penetrating Particles drug delivery technology, with a focus on the treatment of eye diseases. The company's approved ocular corticosteroid product, INVELTYS? (loteprednol etabonate ophthalmic suspension) is used for the treatment of post-operative inflammation and pain. The company is developing KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease. The company is evaluating compounds in its receptor Tyrosine Kinase Inhibitor program that inhibit the vascular endothelial growth factor pathway for the treatment of a number of retinal diseases.

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health. The company offers treatment for hyperammonemia, a metabolic condition generally characterized by elevated levels of ammonia in the blood; infections caused by multi-drug resistant bacteria; chronic kidney disease; atherosclerotic cardiovascular disease; and drug or disease induced diarrhea. The company's product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Macy's Inc

Macy's is an omnichannel retail organization operating stores, websites and mobile applications under three brands (Macy's, Bloomingdale's and bluemercury) that sell merchandise, including apparel and accessories (men's, women's and children's), cosmetics, home furnishings and other consumer goods. The company's wholly-owned bank subsidiary, FDS Bank, provides certain collections, customer service and credit marketing services in respect of all credit card accounts that are owned either by Department Stores National Bank, a subsidiary of Citibank, N.A., or FDS Bank and that constitute a part of the credit programs of the company's retail operations.

Oyster Point Pharma

Oyster Point Pharma is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. The company's lead product candidate OC-01 (varenicline), a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease (DED). OC-01's novel mechanism of action is designed to re-establish tear film homeostasis by activating the trigeminal parasympathetic pathway and stimulating the glands and cells responsible for natural tear film production.

Rideshare Rental Inc

Sierra Bancorp

Sierra Bancorp is a bank holding company. Through its principal subsidiary, Bank of the Sierra, the company provides a range of retail and commercial banking services. The company provides a variety of other banking products and services to complement and support its lending and deposit products, including remote deposit capture and payroll services for business customers. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural, and consumer loans. The company's real estate loans are secured by commercial, office and agricultural properties, but the company also provides commercial construction loans and multifamily credit facilities among other types of loans.

Software Acquisition Group II

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch